Demo corpus. Scores are computed on a select set of biomedical paper/datasets and may be inaccurate for papers outside this corpus — DataRank relies on network effects that improve with scale. We aim to expand this into a fully open resource pending additional funding.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Top 13%
15.2Top 13%
Open Access
5812 citations · base score 8.7
datarank_citation_only_1hop_v4Methodology
›Data sources & pipeline
Pipeline:CrossRefSciBERTdoi-metadataOpenAlexDataRank
Enrichment:Pending
FAIR ChecklistContext only (not used in score)
FFindable
Has DOI
AAccessible
Open Access
IInteroperable
RReusable
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
DataRank Breakdown
Base Component 9%Network Component 91%
Base Score Contribution
1.3
From this paper's citation signal
Citation Network Contribution
13.9
From 166 citing papers with measurable signal
Authors (46)
Frederick L. LockeORCID,Nancy L. BartlettORCID,Lazaros J. LekakisORCID,David B. MiklosORCID,Caron A. JacobsonORCID